Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years

被引:7
作者
Brotons, Carlos [1 ,2 ]
Moral, Irene [1 ,2 ]
Fernandez, Diana [1 ,2 ]
Cuixart, Lluis [2 ,3 ]
Munox, Alex [2 ,3 ]
Soteras, Anna [1 ,2 ]
Puig, Mireia [1 ,2 ]
Joaniquet, Xavier [2 ,3 ]
Casasa, Albert [1 ,2 ]
机构
[1] IIB St Pau, Equip Atencio Primaria Sardenya, Unidad Invest, Barcelona, Spain
[2] Unidad Docente ACEBA, Barcelona, Spain
[3] Equip Atencio Primaria Dreta Eixample, Barcelona, Spain
来源
MEDICINA CLINICA | 2016年 / 147卷 / 09期
关键词
Cardiovascular risk; SCORE; Primary prevention; Elderly; BLOOD-PRESSURE; PREVENTION; DISEASE; SPAIN;
D O I
10.1016/j.medcli.2016.06.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Estimating cardiovascular risk with SCORE is not recommended in persons over 65 years. SCORE investigators have recently published specific tables for older people (SCORE Older Persons [SCORE OP]). The aim of this study is to assess the impact of using SCORE OP tables on a Spanish population aged over 64 years, and compare it with the use of SCORE in patients aged 65-69 years. Patients and method: Cross-sectional study carried out in 2 urban primary health care centres. Individuals between 65 and 85 years old without diabetes or established cardiovascular diseases were included. Cardiovascular risk using SCORE and the new SCORE OP tables for low risk countries was calculated. Results: Cardiovascular risk was estimated in 3,425 patients. Mean values of the original SCORE and SCORE OP were 4.08 and 3.83, respectively in the group of patients aged 65-69 years old (n = 974, 22.44%) (P<.001). The percentage of patients at high or very high risk was 25.46% and 22.90% with the original SCORE and the SCORE OP, respectively (P<.001). Using the original SCORE, 16.43% of the total patients should potentially be treated with lipid lowering drugs, while using the SCORE OP, 13.45% of the patients aged 65-69 years should potentially be treated. Using SCORE OP in patients older than 69 years, 61.49% patients should potentially be treated with lipid lowering drugs. Conclusions: SCORE OP identifies fewer patients at high or very high risk than the original SCORE, therefore, its utilization would imply treating fewer patients of this age with lipid lowering drugs. (C) 2016 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 25 条
  • [21] Sans S, 2007, REV ESP CARDIOL, V60, P476, DOI 10.1016/S1885-5857(07)60188-1
  • [22] Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis
    Teng, Monica
    Lin, Liang
    Zhao, Ying Jiao
    Khoo, Ai Leng
    Davis, Barry R.
    Yong, Quek Wei
    Yeo, Tiong Cheng
    Lim, Boon Peng
    [J]. DRUGS & AGING, 2015, 32 (08) : 649 - 661
  • [23] Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO
  • [24] 2-I
  • [25] Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
    Zethelius, Bjorn
    Berglund, Lars
    Sundstrom, Johan
    Ingelsson, Erik
    Basu, Samar
    Larsson, Anders
    Venge, Per
    Arnlov, Johan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) : 2107 - 2116